BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 75 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,413,000 | +9.6% | 306,223 | +24.8% | 0.00% | 0.0% |
| Q2 2023 | $4,028,000 | -6.2% | 245,299 | -4.5% | 0.00% | 0.0% |
| Q1 2023 | $4,294,000 | +4.4% | 256,980 | -3.6% | 0.00% | 0.0% |
| Q4 2022 | $4,114,000 | +4.3% | 266,611 | +0.9% | 0.00% | 0.0% |
| Q3 2022 | $3,943,000 | -1.3% | 264,134 | +8.6% | 0.00% | 0.0% |
| Q2 2022 | $3,996,000 | -0.5% | 243,200 | +21.4% | 0.00% | 0.0% |
| Q1 2022 | $4,017,000 | -27.1% | 200,265 | -7.9% | 0.00% | 0.0% |
| Q4 2021 | $5,513,000 | -6.6% | 217,383 | -0.6% | 0.00% | -50.0% |
| Q3 2021 | $5,903,000 | +3.2% | 218,768 | +10.6% | 0.00% | 0.0% |
| Q2 2021 | $5,719,000 | +60.3% | 197,743 | +45.8% | 0.00% | +100.0% |
| Q1 2021 | $3,567,000 | +5.0% | 135,626 | +14.4% | 0.00% | 0.0% |
| Q4 2020 | $3,396,000 | +68.2% | 118,524 | +40.0% | 0.00% | 0.0% |
| Q3 2020 | $2,019,000 | +65.9% | 84,675 | +45.5% | 0.00% | – |
| Q2 2020 | $1,217,000 | +177.9% | 58,206 | +137.6% | 0.00% | – |
| Q1 2020 | $438,000 | – | 24,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
| Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
| 1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
| EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
| Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
| Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
| Matisse Capital | 51,296 | $739,175 | 0.52% |
| Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
| Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |